Barry J. Simon insider trades

Open-market stock purchases and sales by Barry J. Simon, Director at ImmunityBio, Inc, from SEC Form 4 filings since Jul 27, 2015.

Recent trades

DateStockTradeValue
Jun 24, 2026IBRX ImmunityBio, IncSold$197K
Jun 4, 2026IBRX ImmunityBio, IncSold$165K
Feb 24, 2026IBRX ImmunityBio, IncSold$901K
Feb 23, 2026IBRX ImmunityBio, IncSold$1.7M
Feb 22, 2026IBRX ImmunityBio, IncSold (not open market)$52.4K
Feb 22, 2026IBRX ImmunityBio, IncBought (not open market)—
Feb 20, 2026IBRX ImmunityBio, IncSold$92.5K
Jan 20, 2026IBRX ImmunityBio, IncSold$503K
Jan 20, 2026IBRX ImmunityBio, IncSold$591K

Companies traded

  • IBRX ImmunityBio, Inc: 10 sales, last Jun 24, 2026
  • VIRX Viracta Therapeutics, Inc: other filings, last Jun 20, 2024
  • NK NantKwest, Inc: 19 sales, last Feb 5, 2021
  • CUE Cue Biopharma, Inc: other filings, last Jan 4, 2021

Get free alerts when Barry J. Simon files a new trade →